US Patent Issued to CAAMTECH on July 1 for "Dialkyl tryptamines and their therapeutic uses" (Washington Inventor)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,328, issued on July 1, was assigned to CAAMTECH INC. (Issaquah, Wash.).

"Dialkyl tryptamines and their therapeutic uses" was invented by Andrew R Chadeayne (Issaquah, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to a compound of formula (I): The disclosure also relates to a compound of formula (Ia): The disclosure relates to compositions comprising, consisting essentially of, or consisting of a compound of formula (I) or formula (Ia) and an excipient. The disclosure also relates to pharmaceutical compositions comprising a therapeutically effective amount of a compound of formula (I) or formula (Ia) where the excipient i...